Comparing diabetes drugs for heart health in prediabetes
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests whether certain diabetes medications can help prevent worsening of heart disease in people who have prediabetes (higher than normal blood sugar, but not yet diabetes). It may be a good fit if you have known coronary artery disease and prediabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have coronary artery disease (blockages in heart arteries seen on a CT scan or after a stent procedure)
- You have prediabetes (fasting blood sugar of 100-125 mg/dL or HbA1c 5.7%-6.4%)
- You are not currently taking any diabetes medications other than metformin
- You do not have diabetes, heart failure, severe kidney disease, or a history of pancreatitis
- You are able to safely participate in physical activity
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether treating prediabetes can help bring blood sugar back to normal. It is for people with heart artery disease who have either prediabetes or normal blood sugar levels, and who haven't been on diabetes medications.
This study looks at how your genes may change how well a GLP-1–type medicine works to improve prediabetes. It focuses on adults at higher risk of developing diabetes, especially people of Mexican-American background.
This trial tests if a drug called dapagliflozin (an SGLT2 inhibitor) can help prevent complications in people with prediabetes when added to lifestyle changes. It aims to see if this approach works better than lifestyle changes alone.
This trial tests canagliflozin to see if it lowers “vascular inflammation” in people with diabetes and stable coronary artery disease. It may help reduce harmful inflammation signals that can raise future heart risk.
This study tests whether a medication called Henagliflozin (a type of SGLT2 inhibitor) can help people with prediabetes return their blood sugar to normal. It is for adults who have not been treated for high blood sugar before.
This trial tests if newer diabetes medications can reduce heart risk and help achieve diabetes remission in people newly diagnosed with type 2 diabetes. It may be an option if you have not taken diabetes drugs before or stopped them over three months ago, and your blood sugar and weight are in certain ranges.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.